Cleveland Clinic Inventor, Thaddeus Stappenbeck, MD, PhD, Receives Sherman Prize for Contributions to IBD Research

Thaddeus Stappenbeck, MD, PhD, has been awarded the prestigious Sherman Prize in recognition of his exceptional and pioneering contributions to transform medical care for people IBD. The Sherman Prize is awarded to three individuals annually by The Bruce and Cynthia Sherman Charitable Foundation.

Dr. Stappenbeck serves as the chair of Inflammation and Immunity at Cleveland Clinic’s Lerner Research Institute. His passion for science, math, and the natural world has lead to groundbreaking discoveries for people with Crohn’s disease and ulcerative colitis, also known as Inflammatory Bowel Disease (IBD). Dr. Stappenbeck’s contribution to the understanding of the microbiome and IBD is exemplary. His innovative use of endoscopic biopsies to study wound healing in the colon has led to significant breakthroughs. Dr. Stappenbeck’s ultimate goal is to ward off disease before it starts using computational methods, big data, and artificial intelligence. He also works with Color of Crohn’s & Chronic Illness to improve access to care and information for people of color, indigenous, and low-income patients with IBD.

“I’m extremely thankful to be recognized by the Sherman Charitable Foundation for research that integrates both patient-facing and lab-facing approaches toward improving the health and well-being of IBD patients,” says Dr. Stappenbeck. “Our goal is to transform laboratory discoveries into new diagnostic testing, therapies and prevention measures for millions of patients suffering from inflammatory intestinal disease.”

Dr. Stappenbeck joined Cleveland Clinic in 2019. He is the founder of Mobius Care, Inc., a Cleveland Clinic Innovations portfolio company that is devoted to developing personized care for inflammatory bowel disease.

To learn more about Dr. Stappenbeck and the Sherman Prize, visit www.shermanprize.org.